MGRX — Mangoceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $23.20m
- $23.12m
- $0.62m
Annual cashflow statement for Mangoceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.018 | -2 | -9.21 | -8.71 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 0 | 0.629 | 2.15 | 2.39 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0 | 0.019 | 0.042 | 0.72 |
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.018 | -1.35 | -7 | -4.86 |
| Capital Expenditures | 0 | -0.043 | -0.004 | — |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | — | 0.065 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | 0 | -0.043 | -0.004 | 0.065 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.04 | 2.05 | 7.06 | 4.13 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.023 | 0.66 | 0.056 | -0.68 |